文献速递心血管CT

冠状动脉斑块的拓扑数据分析揭示冠状动脉粥样硬化的自然病史

Topological Data Analysis of Coronary Plaques Demonstrates the Natural History of Coronary Atherosclerosis.
PubMed 文献 · JACC Cardiovasc Imaging · 2021-01-13

本研究对1264例至少间隔24个月接受两次冠状动脉CT血管成像(CTA)的患者,基于全心脏定量斑块分析构建拓扑数据分析(TDA)患者相似性网络,识别出三个不同患者组及其与结局的关联。TDA网络呈闭环,显示斑块进展的连续趋势;组B急性冠脉综合征发生率高于其他组,组B和组C血运重建发生率高于组A;纳入TDA分组信息可提高预测急性冠脉综合征或血运重建的模型拟合度。

要点

  • 基于冠状动脉CTA全心脏定量斑块特征,TDA可识别三个不同患者组,网络呈闭环并显示斑块进展连续趋势。
  • 组A斑块量最少(中位12.4 mm³),组B斑块量中等(31.7 mm³)且富集纤维脂肪和坏死核心,组C斑块量最大(187.0 mm³)且富集致密钙化。
  • 组B急性冠脉综合征发生率高于其他组(0.3% vs 2.6% vs 0.6%,p=0.009),组B和组C血运重建发生率高于组A(3.1% vs 15.5% vs 17.8%,p<0.001)。

核心结论

  • 基于冠状动脉CTA全心脏定量斑块特征的TDA识别出具有不同斑块动态和临床结局的不同患者组。

研究设计与样本

  • 研究纳入接受两次冠状动脉CTA且间隔至少24个月的患者,共1264例。
  • 基于冠状动脉CTA全心脏定量冠状动脉斑块分析,采用拓扑数据分析构建患者相似性Mapper网络。
  • 研究识别不同患者组并分析其与结局的关联,参考标准为随访期急性冠脉综合征或血运重建。

关键影像表现/征象

  • TDA识别出三个不同患者组,患者相似性网络呈闭环,显示冠状动脉斑块进展的连续趋势。
  • 组A冠状动脉树斑块量最少,中位12.4 mm³(IQR 0.0至39.6 mm³)。
  • 组B斑块量中等,中位31.7 mm³(IQR 0.0至127.4 mm³),纤维脂肪成分占总支架32.6%(IQR 16.7%至46.2%),坏死核心成分占2.7%(IQR 0.1%至6.9%)。
  • 组C斑块量最大,中位187.0 mm³(IQR 96.7至306.4 mm³),致密钙化成分占46.8%(IQR 32.0%至63.7%)。
  • 随访时所有组总斑块体积、纤维成分和致密钙化体积增加,组B和组C纤维脂肪成分比例下降,仅组B坏死核心比例下降(均p<0.05)。

诊断标准与关键数值

  • 组B急性冠脉综合征发生率高于其他组(0.3% vs 2.6% vs 0.6%,p=0.009)。
  • 组B和组C血运重建发生率高于组A(3.1% vs 15.5% vs 17.8%,p<0.001)。
  • 纳入TDA分组信息较纳入临床危险因素、直径狭窄百分比和高危斑块特征,预测急性冠脉综合征或血运重建的模型拟合度提高。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: This study sought to identify distinct patient groups and their association with outcome based on the patient similarity network using quantitative coronary plaque characteristics from coronary computed tomography angiography (CTA).

BACKGROUND: Coronary CTA can noninvasively assess coronary plaques quantitatively.

METHODS: Patients who underwent 2 coronary CTAs at a minimum of 24 months' interval were analyzed (n = 1,264). A similarity Mapper network of patients was built by topological data analysis (TDA) based on the whole-heart quantitative coronary plaque analysis on coronary CTA to identify distinct patient groups and their association with outcome.

RESULTS: Three distinct patient groups were identified by TDA, and the patient similarity network by TDA showed a closed loop, demonstrating a continuous trend of coronary plaque progression. Group A had the least coronary plaque amount (median 12.4 mm3 [interquartile range (IQR): 0.0 to 39.6 mm3]) in the entire coronary tree. Group B had a moderate coronary plaque amount (31.7 mm3 [IQR: 0.0 to 127.4 mm3]) with relative enrichment of fibrofatty and necrotic core (32.6% [IQR: 16.7% to 46.2%] and 2.7% [IQR: 0.1% to 6.9%] of the total plaque, respectively) components. Group C had the largest coronary plaque amount (187.0 mm3 [IQR: 96.7 to 306.4 mm3]) and was enriched for dense calcium component (46.8% [IQR: 32.0% to 63.7%] of the total plaque). At follow-up, total plaque volume, fibrous, and dense calcium volumes increased in all groups, but the proportion of fibrofatty component decreased in groups B and C, whereas the necrotic core portion decreased in only group B (all p < 0.05). Group B showed a higher acute coronary syndrome incidence than other groups (0.3% vs. 2.6% vs. 0.6%; p = 0.009) but both group B and C had a higher revascularization incidence than group A (3.1% vs. 15.5% vs. 17.8%; p < 0.001). Incorporating group information from TDA demonstrated increase of model fitness for predicting acute coronary syndrome or revascularization compared with that incorporating clinical risk factors, percentage diameter stenosis, and high-risk plaque features.

CONCLUSIONS: The TDA of quantitative whole-heart coronary plaque characteristics on coronary CTA identified distinct patient groups with different plaque dynamics and clinical outcomes. (Progression of AtheRosclerotic PlAque DetermIned by Computed TomoGraphic Angiography Imaging [PARADIGM]; NCT02803411).

来源:JACC Cardiovasc Imaging,查看原文。版权归原作者所有。

引用

  1. Hwang D, Kim HJ, Lee SP, et al. Topological Data Analysis of Coronary Plaques Demonstrates the Natural History of Coronary Atherosclerosis. JACC Cardiovasc Imaging. 2021. PMID: 33454260. doi:10.1016/j.jcmg.2020.11.009

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。